Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

China · Delayed Price · Currency is CNY

21.79

+0.17 (0.79%)

Sep 30, 2026, 3:00 PM CST

Market Cap	2.65B +19.3%
Revenue (ttm)	207.51M -20.6%
Net Income	13.68M -68.9%
EPS	0.11 -68.9%
Shares Out	121.78M
PE Ratio	194.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,515,000
Open	21.61
Previous Close	21.62
Day's Range	21.55 - 21.90
52-Week Range	15.70 - 24.25
Beta	0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHA:600671

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces tablets, granules, pills, oral solutions, and other medications; and health food products, including oral liquids, syrups, eye drops, pills, soft capsules, tablets, and granules. It also sells prepared slices of traditional Chinese medicine. In addition, the company operates Chinese medicine clinic; provision of traditional chinese medicine clinic, soft... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1958

Employees 392

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600671

Full Company Profile

Financial Performance

In 2025, SHA:600671's revenue was 211.75 million, a decrease of -2.55% compared to the previous year's 217.30 million. Earnings were 17.62 million, an increase of 15.59%.

Financial Statements